Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Retractable Technologies, Inc.

This article was originally published in The Gray Sheet

Executive Summary

Safety needle manufacturer's shares begin trading May 4 on the American Stock Exchange under the symbol "RVP," primarily shares offered by selling shareholders. The firm plans to offer up to 2 mil. shares of its own at $15 each later. Up to 5.3 mil. shares are being offered initially by certain selling shareholders in the IPO, without the assistance of an underwriter. Proceeds will be used for expansion of manufacturing operations, R&D, and sales and marketing efforts, as the firm moves to capitalize on revised Occupational Safety and Health Administration (OSHA) bloodborne pathogens standards effective April 18 (1"The Gray Sheet" April 23, 2001, p. 13). Little Elm, Texas-based RTI's flagship VanishPoint syringe safety needle line debuted in 1997 and uses a friction ring mechanism for automated retraction of the syringe needle. While the syringe and needle market is dominated by BD (71%), Tyco (22%) and Terumo (7%), RTI has a toehold with 0.25%. Nevertheless, revenues nearly tripled to $9.6 mil. in 2000 versus $3.4 mil. in 1999 with the aid of a May 2000 distribution agreement with Abbott (2"The Gray Sheet" Nov. 13, 2000, p. 19)

You may also be interested in...



Retractable Technologies

New York City-based Investrend Research begins coverage of Little Elm, Texas safety needle maker June 5. Retractable shares began trading May 4 on the American Stock Exchange under the symbol "RVP" (1"The Gray Sheet" May 14 2001, p. 14) Retractable's main product is the VanishPoint syringe, designed to prevent injuries by using a friction ring mechanism for automated retraction of the needle

Retractable Technologies

New York City-based Investrend Research begins coverage of Little Elm, Texas safety needle maker June 5. Retractable shares began trading May 4 on the American Stock Exchange under the symbol "RVP" (1"The Gray Sheet" May 14 2001, p. 14) Retractable's main product is the VanishPoint syringe, designed to prevent injuries by using a friction ring mechanism for automated retraction of the needle

BD To Achieve Safety Products Sales Target Early Aided By OSHA Revision

The Needlestick Safety and Prevention Act and subsequent revision to the Occupational Safety and Health Administration's bloodborne pathogens standard will help BD Corp. reach the $800 mil. sales mark by the end of 2003, the firm is now projecting, well ahead of its earlier forecast of 2005.

UsernamePublicRestriction

Register

OM004514

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel